TGFB1 and atrial fibrillation: These findings indicated that miR-135b exerted antiatrial fibrosis effects in vitro and in vivo by the inhibition of the TGF-β/Smads signaling pathway, thus providing a potential approach for the prevention and treatment of human AF (Wang et al., 2021a).